Literature DB >> 8957066

Metastatic potential of lymphoma/leukemia cell lines in SCID mice is closely related to expression of CD44.

N Kawasaki1, Y Matsuo, T Yoshino, H Yanai, T Oka, N Teramoto, C Liu, E Kondo, J Minowada, T Akagi.   

Abstract

To investigate whether the lymphocyte homing receptors, adhesion molecules regulating normal lymphocyte traffic, influence the dissemination of lymphoma cells, 24 lymphoma/leukemia cell lines were inoculated into SCID mice subcutaneously, and the correlation between the expression of the adhesion molecules and the metastatic potential of the cell lines was examined. Among the six adhesion molecules examined (LFA-1, ICAM-1, CLA, VLA-4, L-selectin and CD44), L-selectin increased the incidence of lymph node metastasis, and CD44 expression was related to both lymph node and organ (hematogenous) metastasis. A monoclonal antibody to the standard form of CD44 (CD44s), Hermes-3, inhibited the local growth and remote metastasis of CD44+ cell lines. Thus, it is concluded that at least CD44s expression is important in both lymphatic and hematogenous metastasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957066      PMCID: PMC5920998          DOI: 10.1111/j.1349-7006.1996.tb03112.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  33 in total

1.  L-selectin-mediated lymphocyte rolling on MAdCAM-1.

Authors:  E L Berg; L M McEvoy; C Berlin; R F Bargatze; E C Butcher
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

Review 2.  Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic.

Authors:  E L Berg; L A Goldstein; M A Jutila; M Nakache; L J Picker; P R Streeter; N W Wu; D Zhou; E C Butcher
Journal:  Immunol Rev       Date:  1989-04       Impact factor: 12.988

Review 3.  Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease.

Authors:  S T Pals; E Horst; R J Scheper; C J Meijer
Journal:  Immunol Rev       Date:  1989-04       Impact factor: 12.988

4.  Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.

Authors:  S Jalkanen; H Joensuu; K O Söderström; P Klemi
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Authors:  G R Screaton; M V Bell; D G Jackson; F B Cornelis; U Gerth; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

6.  Prevention of tumor metastasis formation by anti-variant CD44.

Authors:  S Seiter; R Arch; S Reber; D Komitowski; M Hofmann; H Ponta; P Herrlich; S Matzku; M Zöller
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

7.  CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.

Authors:  R Stauder; W Eisterer; J Thaler; U Günthert
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

8.  Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54).

Authors:  E Horst; C J Meijer; T Radaszkiewicz; G J Ossekoppele; J H Van Krieken; S T Pals
Journal:  Leukemia       Date:  1990-08       Impact factor: 11.528

9.  Amino acid sequence of the human fibronectin receptor.

Authors:  W S Argraves; S Suzuki; H Arai; K Thompson; M D Pierschbacher; E Ruoslahti
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

10.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.

Authors:  K H Heider; M Hofmann; E Hors; F van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

View more
  1 in total

Review 1.  Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms.

Authors:  Peter Valent; Irina Sadovnik; Gregor Eisenwort; Harald Herrmann; Karin Bauer; Niklas Mueller; Wolfgang R Sperr; Daniel Wicklein; Udo Schumacher
Journal:  Semin Cancer Biol       Date:  2019-08-10       Impact factor: 15.707

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.